Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Badley

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Disease Markers|May 1, 1991
Reshaping human monoclonal antibodies for imaging and therapyM E Verhoeyen, J A Saunders, E L Broderick, et al.
Biochimica Et Biophysica Acta|December 15, 1975
The structure, physical and chemical properties of the soy bean protein glycininR A Badley, D Atkinson, H Hauser, et al.
Disease Markers|May 1, 1991
Serological monitoring of advanced breast cancer treated by systemic cytotoxic using a combination of ESR, CEA, and CA 15.3: fact or fiction?A R Dixon, I Jönrup, L Jackson, et al.
Journal of Immunological Methods|January 1, 1981
Propidium iodide as a nuclear marker in immunofluorescence. I. Use with tissue and cytoskeleton studiesC D Ockleford, B L Hsi, J Wakely, et al.
Journal of Microbiological Methods|September 23, 2000
Analysis of bacterial function by multi-colour fluorescence flow cytometry and single cell sortingG Nebe-von-Caron, P J Stephens, C J Hewitt, et al.
British Journal of Cancer|May 1, 1993
The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125J Fisken, J E Roulston, C Sturgeon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1995
Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survivalK V Albuquerque, M R Price, R A Badley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Assessment of four monoclonal antibodies as serum markers in breast cancerJ F Robertson, D Pearson, M R Price, et al.
British Journal of Cancer|November 1, 1991
Tumour localisation with a radioactively labelled reshaped human monoclonal antibodyV Hird, M Verhoeyen, R A Badley, et al.
International Journal of Cancer|September 15, 1989
HMFG1 antigen: a new marker for carcinomatous meningitisR P Moseley, K Oge, S Shafqat, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Disease Markers|May 1, 1991
Reshaping human monoclonal antibodies for imaging and therapyM E Verhoeyen, J A Saunders, E L Broderick, et al.
Biochimica Et Biophysica Acta|December 15, 1975
The structure, physical and chemical properties of the soy bean protein glycininR A Badley, D Atkinson, H Hauser, et al.
Disease Markers|May 1, 1991
Serological monitoring of advanced breast cancer treated by systemic cytotoxic using a combination of ESR, CEA, and CA 15.3: fact or fiction?A R Dixon, I Jönrup, L Jackson, et al.
Journal of Immunological Methods|January 1, 1981
Propidium iodide as a nuclear marker in immunofluorescence. I. Use with tissue and cytoskeleton studiesC D Ockleford, B L Hsi, J Wakely, et al.
Journal of Microbiological Methods|September 23, 2000
Analysis of bacterial function by multi-colour fluorescence flow cytometry and single cell sortingG Nebe-von-Caron, P J Stephens, C J Hewitt, et al.
British Journal of Cancer|May 1, 1993
The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125J Fisken, J E Roulston, C Sturgeon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1995
Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survivalK V Albuquerque, M R Price, R A Badley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Assessment of four monoclonal antibodies as serum markers in breast cancerJ F Robertson, D Pearson, M R Price, et al.
British Journal of Cancer|November 1, 1991
Tumour localisation with a radioactively labelled reshaped human monoclonal antibodyV Hird, M Verhoeyen, R A Badley, et al.
International Journal of Cancer|September 15, 1989
HMFG1 antigen: a new marker for carcinomatous meningitisR P Moseley, K Oge, S Shafqat, et al.
Pageof 5